Category: PharmaceuticalsSyndicate content

Big Data: Johnson & Johnson pledges transparency in clinical trial data

January 30, 2014 by Arezu Sarvestani

Johnson & Johnson vows to open up raw data from its clinical trials in an unparalleled move toward transparency and a potential leap forward in medical data mining.

Big Data: Johnson & Johnson pledges transparency in clinical trial data

Valeant closes $250M acquisition of Solta Medical

January 27, 2014 by Arezu Sarvestani

Valeant Pharmaceuticals consummates its $250 million acquisition of aesthetics maker Solta Medical after completing a tender offer of $2.92 per share for its new subsidiary.

Valeant closes $250M acquisition of Solta Medical

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Shareholders lawsuit against Unilife fizzles

January 23, 2014 by Brad Perriello

The plaintiff in a shareholder's bid for a class action lawsuit against Unilife dismisses the complaint after no other shareholders stepped up to join the suit.

Shareholders lawsuit against Unilife fizzles

The plaintiff in a purported class action shareholders lawsuit against Unilife (NSDQ:UNIS) voluntarily withdrew the complaint after no other stockholders stepped up to join the suit.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medinol, Ariad Pharmaceuticals launch stent trials

January 14, 2014 by Brad Perriello

Medinol and Ariad Pharmaceuticals launch a pair of clinical trials to examine Medinol’s NIRsupreme drug-eluting coronary stent using Ariad's ridaforolimus drug.

Medinol, Ariad Pharmaceuticals launch stent trials
Medinol, Ariad Pharmaceuticals launch stent trials

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Unilife inks another pharma supply deal

December 16, 2013 by Brad Perriello

Unilife says it's inked a supply deal for its Ocu-ject eye drug delivery system with an unspecified pharmaceutical company.

Unilife inks another pharma supply deal

Unilife (NSDQ:UNIS) said it signed a supply deal with an unnamed "global pharmaceutical company" for its Ocu-ject eye drug delivery device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Valeant to pay $250M for Solta Medical

December 16, 2013 by Brad Perriello

Valeant Pharmaceuticals agrees to a $250 million buyout of medical aesthetics company Solta Medical.

Valeant to pay $250M for Solta Medical
Valeant to pay $250M for Solta Medical

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp